These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12436630)

  • 21. Fighting restenosis after coronary angioplasty: contemporary and future treatment options.
    Horlitz M; Sigwart U; Niebauer J
    Int J Cardiol; 2002 Jun; 83(3):199-205. PubMed ID: 12036521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Preventing effect of angiotensin II receptor blocker on neointimal hyperplasia after vascular injury].
    Miyata M; Eto H; Biro S; Tei C
    Nihon Rinsho; 2002 Oct; 60(10):1957-61. PubMed ID: 12397691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin-receptor blockers: revival of the systemic prevention of restenosis?
    Wilensky RL
    Cardiovasc Drugs Ther; 2003 Jan; 17(1):63-73. PubMed ID: 12843688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Impact of statins post percutaneous coronary intervention].
    Taguchi I; Inoue T
    Nihon Rinsho; 2011 Sep; 69 Suppl 7():363-8. PubMed ID: 22519017
    [No Abstract]   [Full Text] [Related]  

  • 25. Rotational atherectomy with drug-eluting stents: a necessary technique in the current era.
    Lozano I; Rondan J; Avanzas P
    Catheter Cardiovasc Interv; 2011 Jan; 77(1):160; author reply 161. PubMed ID: 21069801
    [No Abstract]   [Full Text] [Related]  

  • 26. Secondary prevention of ischaemic cardiac events.
    Gami A
    Clin Evid; 2006 Jun; (15):195-228. PubMed ID: 16973010
    [No Abstract]   [Full Text] [Related]  

  • 27. [Secondary prevention of coronary heart disease. How effective are modern therapy methods?].
    Kolenda KD
    Dtsch Med Wochenschr; 2003 Sep; 128(36):1849-53. PubMed ID: 12964107
    [No Abstract]   [Full Text] [Related]  

  • 28. [Coronary stenting. Does AT-1 blocker protect from restenosis?].
    MMW Fortschr Med; 2003 Nov; 145(46):50. PubMed ID: 14712790
    [No Abstract]   [Full Text] [Related]  

  • 29. The pathophysiology and burden of restenosis.
    Weintraub WS
    Am J Cardiol; 2007 Sep; 100(5A):3K-9K. PubMed ID: 17719351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Palmaz-Schatz stent].
    Kobayashi N; Yamaguchi T
    Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):947-53. PubMed ID: 12436643
    [No Abstract]   [Full Text] [Related]  

  • 31. Individualized approach to the management of coronary heart disease: identifying the nonresponders before it is too late.
    Ganz P; Hsue PY
    J Am Coll Cardiol; 2009 Jan; 53(4):331-3. PubMed ID: 19161881
    [No Abstract]   [Full Text] [Related]  

  • 32. Medical therapy versus percutaneous coronary intervention for patients with stable coronary artery disease.
    Arbab-Zadeh A
    J Am Coll Cardiol; 2009 Feb; 53(6):528-9; author reply 529. PubMed ID: 19195616
    [No Abstract]   [Full Text] [Related]  

  • 33. Contemporary clinical trials of restenosis.
    Paranandi SN; Topol EJ
    J Invasive Cardiol; 1994 May; 6(4):109-24. PubMed ID: 10147167
    [No Abstract]   [Full Text] [Related]  

  • 34. [Involvement of angiotensin II in pathogenesis of hypertension and target organ damage].
    Okigaki M; Iwasaka T
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():139-43. PubMed ID: 15171357
    [No Abstract]   [Full Text] [Related]  

  • 35. Peripheral arterial procedures and postinterventional prophylaxis.
    Kröger K
    J Endovasc Ther; 2006 Feb; 13(1):32-8. PubMed ID: 16445321
    [No Abstract]   [Full Text] [Related]  

  • 36. Vulnerable plaque: scope of the problem.
    Wilensky RL
    J Interv Cardiol; 2008 Dec; 21(6):443-51. PubMed ID: 18973505
    [No Abstract]   [Full Text] [Related]  

  • 37. Adjunctive pharmacotherapy before percutaneous coronary intervention in non-ST-elevation acute coronary syndromes: the role of modulating inflammation.
    Kereiakes DJ
    Circulation; 2003 Oct; 108(16 Suppl 1):III22-7. PubMed ID: 14605016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluvastatin for the prevention of restenosis after coronary balloon angioplasty: angiographic and methodological background of the fluvastatin angioplasty restenosis trial.
    Foley DP; Serruys PW
    Br J Clin Pract Suppl; 1996 Jan; 77A():40-53. PubMed ID: 8729590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluvastatin for the prevention of restenosis after coronary balloon angioplasty: angiographic and methodological background of the fluvastatin angioplasty restenosis trial.
    Foley DP; Serruys PW
    Br J Clin Pract Suppl; 1994 Dec; (77):39-50. PubMed ID: 19496272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Drug-eluting stents do they make the difference? ].
    Presbitero P; Asioli M
    Minerva Cardioangiol; 2002 Oct; 50(5):431-42. PubMed ID: 12384625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.